Open Source Drug Development Manifesto?

The pharmaceutical industry of the future will require, at least in part, a robust, globally accessible informatics infrastructure available to industry, academic, regulators, and NGOs.  In some cases, accessibility may even be extended to patients. 

The system will need to be flexible enough to permit rapid and accurate data sharing among disparate actors, systems, and institutions.  This innovation and collaborative thinking is already being applied in isolated cases.  For example, Pfizer, UK National Health Service trusts, Scottish Enterprise, and Scottish universities started a Translational Medicine Research Collaboration applying these principles to create a mini global network. 

However, what is needed is a truly global network that includes multiple large biopharma companies, in addition to many other actors from the private, public, and NGO sectors.